Insider Selling: Adtalem Global Education (NYSE:CVSA) Insider Sells $249,000.00 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) insider Karen Sue Cox sold 2,000 shares of Adtalem Global Education stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $124.50, for a total transaction of $249,000.00. Following the sale, the insider owned 31,596 shares of the company’s stock, valued at approximately $3,933,702. The trade was a 5.95% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Shares of Adtalem Global Education stock opened at $126.55 on Friday. Adtalem Global Education Inc. has a 1 year low of $86.97 and a 1 year high of $156.26. The company has a market capitalization of $4.31 billion, a price-to-earnings ratio of 19.71, a PEG ratio of 1.07 and a beta of 0.63. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36. The company’s 50 day moving average is $113.50.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. The firm had revenue of $487.03 million during the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, research analysts anticipate that Adtalem Global Education Inc. will post 8.03 earnings per share for the current year.

Analysts Set New Price Targets

CVSA has been the subject of a number of recent research reports. Truist Financial boosted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday. Barrington Research restated an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a report on Friday, April 17th. Wall Street Zen lowered shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Zacks Research lowered shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Finally, Weiss Ratings initiated coverage on shares of Adtalem Global Education in a report on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.